earnings
confidence high
sentiment negative
materiality 0.80
Medifast Q1 revenue $76M, down 34% YoY; net loss $2.1M; guides Q2 revenue $60-80M
MEDIFAST INC
2026-Q1 EPS reported
-$0.19
revenue$76,044,000
- Revenue fell 34.3% to $76.0M; net loss widened to $2.1M ($0.19 EPS) from $0.8M loss.
- Active earning coaches dropped 44.9% to 14,000; rev per coach up 19.2% to $5,432.
- Gross margin 68.1% vs 72.8% a year ago; operating loss $3.3M vs $1.3M.
- Outlook: Q2 rev $60-80M, EPS loss $0.50-$1.00; FY rev $270-300M, EPS loss $1.55-$2.75.
- Cash $168.9M, no debt; expects active earning coaches to continue declining in 2026.